Suppression of NGALR impedes TNBC cell survival, proliferation, invasion, and migration through Akt/mTOR and JAK/STAT3 pathway inhibition.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Clinical and Translational Oncology

• Publication date

  2025-11-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12094-025-04081-yPMID 41212350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epithelial-mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges

  2025cited by this paper
• Mutational spectrum of BRCA genes in Egyptian patients with breast cancer

  2025cited by this paper
• Targeting kinases that regulate programmed cell death: a new therapeutic strategy for breast cancer

  2025cited by this paper
• Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer

  2024cited by this paper
• Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

  2024cited by this paper
• Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database

  2023cited by this paper
• CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment

  2023cited by this paper
• Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models

  2022cited by this paper
• Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer

  2022cited by this paper
• An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer

  2022cited by this paper
• Breast cancer in India: Present scenario and the challenges ahead

  2022cited by this paper
• How VEGF-A and its splice variants affect breast cancer development – clinical implications

  2022cited by this paper
• Cancer statistics, 2022

  2022cited by this paper
• Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective

  2022cited by this paper
• Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation

  2022cited by this paper
• The Role of Radiomics and AI Technologies in the Segmentation, Detection, and Management of Hepatocellular Carcinoma

  2022cited by this paper
• Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis

  2022cited by this paper
• Current and future burden of breast cancer: Global statistics for 2020 and 2040

  2022cited by this paper
• Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness

  2022cited by this paper
• Triple negative breast cancer: Pitfalls and progress

  2022cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• Development of an SNP Assay for Marker-Assisted Selection of Soil-Borne Rhizoctonia solani AG-2-2-IIIB Resistance in Sugar Beet

  2021cited by this paper
• Human breast tumor derived endothelial cells exhibit distinct biological properties

  2021cited by this paper
• Impact of Epithelial–Mesenchymal Transition on the Immune Landscape in Breast Cancer

  2021cited by this paper
• Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020

  2021cited by this paper
• Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic Treatment

  2021cited by this paper
• The Multifaceted Functions of Autophagy in Breast Cancer Development and Treatment

  2021cited by this paper
• A Novel Ferroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Breast Cancer

  2021cited by this paper
• Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis

  2021cited by this paper
• Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transition

  2021cited by this paper
• Overview of recent advances in metastatic triple negative breast cancer

  2021cited by this paper
• A Novel Ferroptosis-Related Gene Signature Predicts Overall Survival of Breast Cancer Patients

  2021cited by this paper
• Advanced Approaches to Breast Cancer Classification and Diagnosis

  2021cited by this paper
• Tumor microenvironment promotes breast cancer chemoresistance

  2021cited by this paper
• Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation

  2020cited by this paper
• Interleukin-6–mediated epigenetic control of the VEGFR2 gene induces disorganized angiogenesis in human breast tumors

  2020cited by this paper
• Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology

  2020cited by this paper
• Triple-negative breast cancer molecular subtyping and treatment progress

  2020cited by this paper
• A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns

  2020cited by this paper
• Arnicolide D Inhibits Triple Negative Breast Cancer Cell Proliferation by Suppression of Akt/mTOR and STAT3 Signaling Pathways

  2020cited by this paper
• Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer

  2020cited by this paper
• An Iron Metabolism-Related SLC22A17 for the Prognostic Value of Gastric Cancer

  2020cited by this paper
• Association Between Serum Iron Biomarkers and Breast Cancer

  2020cited by this paper
• The lingering mysteries of metastatic recurrence in breast cancer

  2020cited by this paper
• Inhibition of Akt/mTOR pathway overcomes intrinsic resistance to dasatinib in triple-negative breast cancer.

  2020cited by this paper
• Inflection of Akt/mTOR/STAT-3 cascade in TIPE mediated human lung carcinogenesis.

  2020cited by this paper
• Relation of Neutrophil Gelatinase-Associated Lipocalin Overexpression to the Resistance to Apoptosis of Tumor B Cells in Chronic Lymphocytic Leukemia

  2020cited by this paper
• Epithelial-to-Mesenchymal Transition and invadopodia markers in breast cancer: Lumican a key regulator.

  2020cited by this paper
• Differential expression and prognostic relevance of autophagy-related markers ATG4B, GABARAP, and LC3B in breast cancer

  2020cited by this paper
• Vietnamese coriander inhibits cell proliferation, survival and migration via suppression of Akt/mTOR pathway in oral squamous cell carcinoma

  2019cited by this paper
• Iron as a Central Player and Promising Target in Cancer Progression

  2019cited by this paper
• Iron metabolism and its contribution to cancer (Review).

  2019cited by this paper
• Cancer drug development: The missing links

  2019cited by this paper
• Abstract P2-01-03: Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion

  2019cited by this paper
• Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma

  2019cited by this paper
• Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge

  2019cited by this paper
• KISS1 in breast cancer progression and autophagy

  2019cited by this paper
• TIPE2 Induced the Proliferation, Survival, and Migration of Lung Cancer Cells Through Modulation of Akt/mTOR/NF-κB Signaling Cascade

  2019cited by this paper
• Cryptotanshinone from the Salvia miltiorrhiza Bunge Attenuates Ethanol-Induced Liver Injury by Activation of AMPK/SIRT1 and Nrf2 Signaling Pathways

  2019cited by this paper
• Oridonin inhibits VEGF-A-associated angiogenesis and epithelial-mesenchymal transition of breast cancer in vitro and in vivo

  2018cited by this paper
• Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin

  2018cited by this paper
• JAK2 and PD‐L1 Amplification Enhance the Dynamic Expression of PD‐L1 in Triple‐negative Breast Cancer

  2018cited by this paper
• Differential expression and clinical significance of epithelial-mesenchymal transition markers among different histological types of triple-negative breast cancer

  2018cited by this paper
• Metastatic and triple-negative breast cancer: challenges and treatment options

  2018cited by this paper
• Differences in molecular features of triple‐negative breast cancers based on the age at diagnosis

  2018cited by this paper
• The expression analysis of NGAL and NGALR in clear cell renal cell carcinoma.

  2018cited by this paper
• NGAL is Downregulated in Oral Squamous Cell Carcinoma and Leads to Increased Survival, Proliferation, Migration and Chemoresistance

  2018cited by this paper
• Alarming Burden of Triple‐Negative Breast Cancer in India

  2017cited by this paper
• Snail maintains metastatic potential, cancer stem-like properties, and chemoresistance in mesenchymal mouse breast cancer TUBO‑P2J cells.

  2017cited by this paper
• EMT promoting transcription factors as prognostic markers in human breast cancer

  2017cited by this paper
• Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer

  2017cited by this paper
• Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer1

  2016cited by this paper
• Prognostic Value of E-Cadherin and β-Catenin in Triple-Negative Breast Cancer.

  2016cited by this paper
• Decreased expression of autophagy protein LC3 and stemness (CD44+/CD24-/low) indicate poor prognosis in triple-negative breast cancer.

  2016cited by this paper
• Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence

  2016cited by this paper
• siRNA induces gelsolin gene transcription activation in human esophageal cancer cell

  2015cited by this paper
• RNA-Based TWIST1 Inhibition via Dendrimer Complex to Reduce Breast Cancer Cell Metastasis

  2015cited by this paper
• Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer

  2014cited by this paper
• Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patients.

  2014cited by this paper
• Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers

  2014cited by this paper
• Effects and mechanism of downregulation of COX‑2 expression by RNA interference on proliferation and apoptosis of human breast cancer MCF‑7 cells.

  2014cited by this paper
• HIC1 silencing in triple-negative breast cancer drives progression through misregulation of LCN2.

  2014cited by this paper
• Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis.

  2014cited by this paper
• Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings.

  2013cited by this paper
• Breast cancer status in India: An overview

  2013cited by this paper
• Vimentin as a poor prognostic factor for triple-negative breast cancer

  2013cited by this paper
• High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer

  2013cited by this paper
• NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.

  2012cited by this paper
• NGAL and NGALR are frequently overexpressed in human gliomas and are associated with clinical prognosis

  2011cited by this paper
• The role of iron in tumour cell proliferation

  2011cited by this paper
• Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17, SLC22A17) and its prognostic significance in endometrial carcinoma.

  2011cited by this paper
• Epithelial-mesenchymal Transition and Cell Invasion

  2010cited by this paper
• Overexpression of neutrophil gelatinase-associated lipocalin and its receptor in colorectal carcinoma: Significant correlation with cell differentiation and tumour invasion.

  2010cited by this paper
• Neutrophil gelatinase-associated lipocalin and its receptor: independent prognostic factors of oesophageal squamous cell carcinoma

  2010cited by this paper
• Correlation of Snail expression and survival in patients with early-stage triple-negative breast cancer (TNBC).

  2010cited by this paper
• Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years

  2009cited by this paper
• Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase‐independent pathway

  2008cited by this paper
• Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells

  2008cited by this paper
• NGALR Is Overexpressed and Regulated by Hypomethylation in Esophageal Squamous Cell Carcinoma

  2008cited by this paper
• A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake.

  2005cited by this paper

• Female Serum HER2 Expression: Its Association With Metabolic Syndrome and Treatment Drug Response

  2026cites this paper